Carlos Gamboa-Vignolle

Summary

Publications

  1. pmc Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases
    Luis L Rojas-Puentes
    Medical Oncology Department, Instituto Nacional de Cancerología de México INCan, San Fernando N22 Colonia Sección XVI, Tlalpan Mexico City, Mexico
    Radiat Oncol 8:209. 2013
  2. ncbi request reprint Whole-brain irradiation with concomitant daily fixed-dose temozolomide for brain metastases treatment: a randomised phase II trial
    Carlos Gamboa-Vignolle
    Department of Radiation Oncology, Instituto Nacional de Cancerología INCan, Mexico City, Mexico
    Radiother Oncol 102:187-91. 2012
  3. ncbi request reprint Clinical features and prognostic factors in patients with carcinomatous meningitis secondary to breast cancer
    Fernando Lara-Medina
    Departments of Medical Oncology, Instituto Nacional de Cancerologia, Mexico City, Mexico
    Breast J 18:233-41. 2012
  4. pmc Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer
    Alberto Alvarado-Miranda
    Department of Medical Oncology, Instituto Nacional de Cancerologia, Mexico City, Mexico
    Radiat Oncol 4:24. 2009

Collaborators

  • Oscar Arrieta
  • Alberto Alvarado-Miranda
  • Luis L Rojas-Puentes
  • Marcelino González-Pinedo
  • Fernando Lara-Medina
  • Claudia Arce-Salinas
  • Rodrigo Núñez-Gómez
  • Yusmiren Dorantes-Gallareta
  • Alejando Crismatt
  • Alette Ortega-Gómez
  • J D Salvador Ruiz-González
  • Alejandro Crismatt
  • Lorena Flores-Hernández
  • Cynthia Villarreal-Garza

Detail Information

Publications4

  1. pmc Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases
    Luis L Rojas-Puentes
    Medical Oncology Department, Instituto Nacional de Cancerología de México INCan, San Fernando N22 Colonia Sección XVI, Tlalpan Mexico City, Mexico
    Radiat Oncol 8:209. 2013
    ..In this phase II study, we evaluated the efficacy and safety of radiosensibilization using CLQ concomitant with 30 Gray (Gy) of whole-brain irradiation (WBI) to treat patients with brain metastases (BM) from solid tumors...
  2. ncbi request reprint Whole-brain irradiation with concomitant daily fixed-dose temozolomide for brain metastases treatment: a randomised phase II trial
    Carlos Gamboa-Vignolle
    Department of Radiation Oncology, Instituto Nacional de Cancerología INCan, Mexico City, Mexico
    Radiother Oncol 102:187-91. 2012
    ..This randomised phase II study evaluated the use of Temozolomide (TMZ) concomitant with 30 Gray (Gy) of Whole-brain irradiation (WBI) for 2 weeks without adjuvant TMZ vs. WBI alone in patients with Brain metastases (BM) from solid tumours...
  3. ncbi request reprint Clinical features and prognostic factors in patients with carcinomatous meningitis secondary to breast cancer
    Fernando Lara-Medina
    Departments of Medical Oncology, Instituto Nacional de Cancerologia, Mexico City, Mexico
    Breast J 18:233-41. 2012
    ..001). These factors can identify a subgroup of patients who are candidates for an intensive management approach...
  4. pmc Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer
    Alberto Alvarado-Miranda
    Department of Medical Oncology, Instituto Nacional de Cancerologia, Mexico City, Mexico
    Radiat Oncol 4:24. 2009
    ..The aim of this study was to analyze in a retrospective manner the effectiveness of concurrent chemo-radiotherapy (CCRTh) after neoadjuvant chemotherapy (NCT) in patients with LABC...